Background Multinational clinical trials efficiently pool resources and provide treatment comparisons across diverse populations. However, they may be difficult to interpret when there are larger than expected differences in region-specific treatment effects, such as a positive study that includes regions favoring the control arm. Purpose This article investigates the extent of chance variation that can be expected in regional treatment effects from multinational studies. It advocates studying this expected variation during the design stage, hence limiting the potential for surprises and misinterpretations at the end of the study. Methods The theory of order statistics was used to quantify chance variation between regions, assuming a homoge...
Noninferiority multiregional clinical trials (MRCTs) have recently received increasing attention in ...
Noninferiority multiregional clinical trials (MRCTs) have recently received increasing attention in ...
[[abstract]]To accelerate the drug development process and shorten approval time, the design of mult...
[[abstract]]In recent years, global collaboration has become a conventional strategy for new drug de...
With the increasing globalization of clinical trials, the opportunity exists to explore potential ge...
[[abstract]]In recent years, global collaboration has become a conventional strategy for new drug de...
Globalized drug development studies, such as multiregional clinical trials (MRCTs), have attracted m...
[[abstract]]Globalized drug development studies, such as multiregional clinical trials (MRCTs), have...
[[abstract]]To speed up drug development to allow faster access to medicines for patients globally, ...
[[abstract]]Globalized drug development studies, such as multiregional clinical trials (MRCTs), have...
[[abstract]]Globalized drug development studies, such as multiregional clinical trials (MRCTs), have...
[[abstract]]To speed up drug development to allow faster access to medicines for patients globally, ...
[[abstract]]In recent years, global collaboration has become a commonly used strategy for new drug d...
Multi-country randomised clinical trials (MRCTs) are common in the medical literature, and their int...
[[abstract]]In recent years, global collaboration has become a commonly used strategy for new drug d...
Noninferiority multiregional clinical trials (MRCTs) have recently received increasing attention in ...
Noninferiority multiregional clinical trials (MRCTs) have recently received increasing attention in ...
[[abstract]]To accelerate the drug development process and shorten approval time, the design of mult...
[[abstract]]In recent years, global collaboration has become a conventional strategy for new drug de...
With the increasing globalization of clinical trials, the opportunity exists to explore potential ge...
[[abstract]]In recent years, global collaboration has become a conventional strategy for new drug de...
Globalized drug development studies, such as multiregional clinical trials (MRCTs), have attracted m...
[[abstract]]Globalized drug development studies, such as multiregional clinical trials (MRCTs), have...
[[abstract]]To speed up drug development to allow faster access to medicines for patients globally, ...
[[abstract]]Globalized drug development studies, such as multiregional clinical trials (MRCTs), have...
[[abstract]]Globalized drug development studies, such as multiregional clinical trials (MRCTs), have...
[[abstract]]To speed up drug development to allow faster access to medicines for patients globally, ...
[[abstract]]In recent years, global collaboration has become a commonly used strategy for new drug d...
Multi-country randomised clinical trials (MRCTs) are common in the medical literature, and their int...
[[abstract]]In recent years, global collaboration has become a commonly used strategy for new drug d...
Noninferiority multiregional clinical trials (MRCTs) have recently received increasing attention in ...
Noninferiority multiregional clinical trials (MRCTs) have recently received increasing attention in ...
[[abstract]]To accelerate the drug development process and shorten approval time, the design of mult...